Earnings History Data for LAVA Therapeutics (LVTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
LAVA Therapeutics
LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy. LAVA Therapeutics B.V. is based in UTRECHT, The Netherlands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-12-2024 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.46 | -0.35 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.46 misses by $0.13 [12/10/2024 7:39 AM] |
1.46 | -0.45 (-23.82%) |
1.72 | -0.19 (-9.95%) |
1.35 - 6.47 | 484,139 | 80,000 | 59,822 | ||
| 20-08-2024 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.31 | -0.33 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.31 beats by $0.03 [8/20/2024 7:33 AM] |
1.81 | -0.01 (-0.55%) |
1.83 | 0.01 (0.55%) |
1.13 - 6.47 | 67,032 | 50,000 | 3,602 | ||
| 21-05-2024 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.02 | -0.25 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.02 beats by $0.20, revenue of $6.99M beats by $3.49M [5/21/2024 7:37 AM] |
2.64 | -0.06 (-2.22%) |
2.81 | 0.11 (4.07%) |
1.13 - 6.47 | 73,358 | 60,000 | 1,676 | ||
| 20-03-2024 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.24 | 0.16 | 0.00 | 3.08 | -0.11 (-3.45%) |
3.18 | -0.01 (-0.31%) |
1.13 - 6.47 | 469,854 | 540,000 | 34,211 | |||
|
|
||||||||||||||||||
| 16-11-2023 | PM | LVTX | LAVA Therapeutics N.V. | 36.81 | -0.34 | -0.48 | 0.04 | LAVA Therapeutics GAAP EPS of -$0.34 beats by $0.14 [11/16/2023 7:17 AM] |
1.49 | 0.0 (0.00%) |
1.42 | -0.07 (-4.70%) |
1.13 - 7.38 | 26,518 | 90,000 | 1,268 | ||
| 22-08-2023 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.48 | -0.48 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.48 beats by $0.02, revenue of $5.14M [8/22/2023 8:49 AM] |
1.74 | -0.06 (-3.33%) |
1.81 | 0.01 (0.56%) |
1.37 - 7.38 | 29,909 | 30,000 | 1,397 | ||
| 08-06-2023 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.53 | -0.47 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.53, revenue of $1.22M [6/8/2023 8:52 AM] |
2.56 | 0.32 (14.29%) |
2.27 | 0.03 (1.34%) |
1.37 - 7.38 | 1,215,256 | 3,670,000 | 48,649 | ||
| 11-04-2023 | PM | LVTX | LAVA Therapeutics | 0.00 | -0.57 | -0.50 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.57, revenue of $2.64M [4/11/2023 7:32 AM] |
1.43 | 0.03 (2.14%) |
0.0 | 0.0 (0.00%) |
1.37 - 7.38 | 51,718 | 40,000 | 0 | ||
| 16-11-2022 | AH | 4:05 PM ET (Nov 16) |
LVTX | LAVA Therapeutics | 133.00 | 0.04 | -0.07 | 0.00 | LAVA Therapeutics GAAP EPS of $0.04 beats by $0.18, revenue of $15.26M beats by $4.73M [11/16/2022 5:24 PM] |
5.00 | 0.20 (4.17%) |
0.0 | 0.0 (0.00%) |
2.28 - 7.89 | 42,731 | 30,000 | 0 | |
| 17-05-2022 | PM | 6:30 AM ET (May 17) |
LVTX | LAVA Therapeutics | 101.00 | -0.41 | -0.95 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.41 beats by $0.44, revenue of $1M beats by $0.46M [5/17/2022 8:01 AM] |
3.58 | -0.23 (-6.04%) |
4.05 | 0.24 (6.30%) |
3.22 - 13.13 | 7,226 | 10,000 | 203 | |
| 24-03-2022 | PM | LVTX | LAVA Therapeutics | 119.00 | -0.38 | -0.38 | 0.00 | LAVA Therapeutics GAAP EPS of -$0.38 misses by $0.01, revenue of $1M [3/24/2022 7:10 AM] |
4.94 | 0.16 (3.46%) |
0.0 | 0.0 (0.00%) |
4.22 - 17.20 | 7,173 | 19,744 | 0 | ||
| 16-08-2021 | PM | LVTX | Lava Therapeutics N.v. | 139.00 | -0.28 | -0.31 | 0.00 | LAVA Therapeutics reports Q2 results [8/16/2021 8:44 AM] |
5.73 | 0.02 (0.35%) |
5.72 | 0.01 (0.18%) |
5.50 - 17.20 | 62,780 | 710,000 | 104 | ||